Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 1601-1650 of 6028 result(s).
CYDY CytoDyn Inc
03/29/2022 11:45:27 PM
Our trial size would not amount to (1)
CYDY CytoDyn Inc
03/25/2022 9:27:12 AM
You all need to chillax on these st (5)
CYDY CytoDyn Inc
03/19/2022 1:09:56 AM
nmbr1stckpckr what an odd name your (1)
CYDY CytoDyn Inc
03/18/2022 6:28:40 PM
I'm certain current management is g (11)
CYDY CytoDyn Inc
03/18/2022 5:01:55 PM
they are facts Your claim of facts (5)
CYDY CytoDyn Inc
03/18/2022 11:26:23 AM
CYDY cannot do anything except brin (19)
CYDY CytoDyn Inc
03/18/2022 2:31:37 AM
A little added color. Most likely b (2)
CYDY CytoDyn Inc
03/16/2022 3:32:26 PM
only lost some when I had to give t (3)
CYDY CytoDyn Inc
03/16/2022 3:18:57 PM
I had my doubts about DrD until a p (7)
CYDY CytoDyn Inc
03/16/2022 3:15:42 PM
Ukraine has raised the bar in terms (7)
CYDY CytoDyn Inc
03/16/2022 2:59:18 PM
I just want people to know I am not (3)
CYDY CytoDyn Inc
03/15/2022 8:24:53 PM
I truly do not believe that anythin (15)
CYDY CytoDyn Inc
03/15/2022 8:12:25 PM
Doesn’t paint the entire picture (3)
CYDY CytoDyn Inc
03/14/2022 9:03:42 PM
I have a couple of sets of lockpick (3)
CYDY CytoDyn Inc
03/14/2022 5:18:10 PM
The next 10Q, IMHO, is most likely (5)
CYDY CytoDyn Inc
03/14/2022 5:12:21 PM
With the amount of shares traded da (6)
CYDY CytoDyn Inc
03/14/2022 5:08:56 PM
With the information that you said (2)
CYDY CytoDyn Inc
03/14/2022 5:00:51 PM
The Cancer Moonshot program is main (2)
CYDY CytoDyn Inc
03/14/2022 4:55:04 PM
We haven’t sold shares or can’t (2)
CYDY CytoDyn Inc
03/14/2022 4:52:49 PM
That's the way that company sees it (4)
CYDY CytoDyn Inc
03/14/2022 4:34:27 PM
They have nothing (all results did (8)
CYDY CytoDyn Inc
03/14/2022 4:26:31 PM
That guy is just someone else who i (7)
CYDY CytoDyn Inc
03/14/2022 8:30:14 AM
I feel strongly that CFS and probab (4)
CYDY CytoDyn Inc
03/13/2022 2:03:55 PM
I would have to go back and look at (5)
CYDY CytoDyn Inc
03/12/2022 6:10:19 AM
Dr Patterson dismisses the question (6)
CYDY CytoDyn Inc
03/12/2022 6:00:57 AM
The law firm handling that lawsuit (3)
CYDY CytoDyn Inc
03/11/2022 3:33:31 PM
Arbitration may be shorter then a c (1)
CYDY CytoDyn Inc
03/11/2022 2:09:14 PM
You'll have to wait until the curre (2)
CYDY CytoDyn Inc
03/11/2022 2:07:44 PM
How many years does it take for a b (4)
CYDY CytoDyn Inc
03/11/2022 12:28:10 PM
CYDY should have dealt with Amarex (10)
CYDY CytoDyn Inc
03/11/2022 10:50:24 AM
Amarex wouldn't let Cytodyn do an a (6)
CYDY CytoDyn Inc
03/11/2022 10:46:39 AM
I would really like to see the Amar (8)
CYDY CytoDyn Inc
03/11/2022 3:48:46 AM
I would think that if antihistamine
CYDY CytoDyn Inc
03/10/2022 6:57:01 PM
You mean the BLA that Amarex had co (10)
CYDY CytoDyn Inc
03/10/2022 6:48:28 PM
Rubraquercus doesn't care that the (9)
CYDY CytoDyn Inc
03/10/2022 6:45:47 PM
CytoDyn throw out generalized, non- (7)
CYDY CytoDyn Inc
03/10/2022 6:31:30 PM
Please explain why the FDA refuses (7)
CYDY CytoDyn Inc
03/09/2022 11:01:37 PM
I miss all the fun. :( (2)
CYDY CytoDyn Inc
03/09/2022 3:34:57 PM
The social responsibility of a busi (4)
CYDY CytoDyn Inc
03/09/2022 1:23:47 PM
I thought we already completed the (14)
CYDY CytoDyn Inc
03/09/2022 1:03:40 PM
That says nothing about the 22 canc (6)
CYDY CytoDyn Inc
03/09/2022 12:54:22 PM
Study completion date for CD03 was (14)
CYDY CytoDyn Inc
03/08/2022 7:48:34 PM
On the pipeline completed Phase 2 t (6)
CYDY CytoDyn Inc
03/08/2022 1:54:21 PM
The mindset of our de facto leader (1)
CYDY CytoDyn Inc
03/08/2022 10:55:46 AM
I believe there were two sites list (2)
CYDY CytoDyn Inc
03/08/2022 10:47:50 AM
Why I wonder? The FDA and managemen (4)
CYDY CytoDyn Inc
03/07/2022 3:12:38 PM
Here's a similar article that expla (7)
CYDY CytoDyn Inc
03/06/2022 9:42:24 PM
Do you see any differences in the t (6)
CYDY CytoDyn Inc
03/05/2022 3:27:28 PM
The finding suggests that symptoms (6)
CYDY CytoDyn Inc
03/05/2022 3:08:12 PM
Market makers are supposed to provi (7)
Go to page:
  • << First
  • < Previous
  • 32
  • 33
  • Next >

Recent Articles

  • Class Action Lawsuit Alert for Investors of Nutex Health Inc.
  • Investigating Investor Claims: Novo Nordisk Holdings Potential
  • Hammond Power Solutions Announces Quarterly Dividend Details
  • Acuity Inc. Set to Unveil Fourth-Quarter Results Soon
  • Cascade Prodrug Expands Board with Experienced Leaders in Oncology
  • Petrus Resources Shares the Latest Monthly Operational Update
  • First Savings Financial Group Announces Quarterly Dividend Update
  • Privia Health Reports Remarkable $233 Million Savings in 2024
  • ROHM Showcases Innovative Technologies at electronica India 2025
  • Knighted Pastures Withdraws Proxy Contest with Allied Gaming
  • Transform Your Investment: Discover KB Home's Surprising Growth
  • Examining Challenges Facing Canadian Workers This Labour Day
  • Autodesk (ADSK) Sees 10% Surge Following Impressive Q2 Results
  • Petco's Remarkable Q2 Earnings Growth Stuns Investors
  • Elemental Altus Enhances Capital Management with Digital Gold
  • Vanda Pharmaceuticals Set for Major Investor Conferences Soon
  • Growth Surge in GSK 3 Inhibitor Market: Innovations and Insights
  • ROHM Semiconductor Highlights Innovations at Electronica India
  • Understanding PNW Residents’ Preparedness for Major Earthquakes
  • First Savings Financial Group Declares Cash Dividend for Investors
  • Koss Corporation's Year-End Financial Insights Unveiled
  • Hammond Power Solutions Announces Latest Quarterly Dividend Update
  • Acuity Inc. to Reveal Fiscal 2025 Results and Insights Soon
  • Boardwalktech Reports Q1 Fiscal 2026 Financial Overview
  • BQE Water Inc. Achieves Record Performance in Q2 2025
  • Kane Biotech Reports Q2 2025 Financial Performance Update
  • Starlight U.S. Residential Fund Reports Q2-2025 Results
  • Nanalysis Scientific Corp. Reports Q2 2025 Financial Results
  • Koss Corporation's Fourth Quarter Performance Report Analysis
  • XLCS Partners Facilitates NSL Aerospace's Strategic Sale
  • Nanalysis Reports Second Quarter 2025 Financial Performance
  • Kane Biotech Discusses Q2 2025 Results and Future Plans
  • Key Leadership Transitions at AutoZone: A New Era Begins
  • Lands' End Plans Exciting Conference Call for Q2 Earnings
  • NVIDIA Set to Shine at Key Financial Event Next Month
  • Lithium Ionic Corp Shares AGM Outcomes and Future Goals
  • Leadership Transition at AutoZone: New Faces on Board
  • Analyzing Illinois Tool Works Inc's Stock Performance Metrics
  • The Surprising Growth of Microsoft Stock Over 20 Years
  • Class Action Lawsuit Filed Against PubMatic: Investor Alert
  • IREN Limited Sees Impressive Earnings Growth and NVIDIA Status
  • Class Action Lawsuit for LifeMD, Inc. Shareholders and Investors
  • Dell Technologies Reports Strong Q2 Results Amid AI Growth
  • Dr. Douglas Farris Joins Hopkins Dermatology Team to Enhance Care
  • Understanding the Pressures of the Transportation Sector
  • Breitling Partners with NFL: A New Era in Luxury Timepieces
  • Boardwalktech Posts Q1 FY26 Results Showcasing Strategic Growth
  • Wesco International Announces Exciting Quarterly Dividend
  • Unicycive Therapeutics Faces Legal Challenges in Securities Case
  • Texas Veterans Challenge Lt. Governor Over Hemp Products Ban
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site